The plasma glucose lowering action of tetrandrine in streptozotocin-induced diabetic rats

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 5, 2004, Pages 643-648

  Chen, Wang Chuan ^a   Hayakawa, Satoshi ^a   Yamamoto, Tatsuo ^a   Huang, Lee Wen ^b   Liu, I Min ^c   Cheng, Juei Tang ^b  

^a NIHON UNIVERSITY   (Japan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN; INSULIN; PENTOBARBITAL; STREPTOZOCIN; TETRANDRINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG MECHANISM; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; INSULIN DEFICIENCY; ISOLATION PROCEDURE; LIVER CELL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROVOCATION TEST; RAT; SOLEUS MUSCLE; STEPHANIA TETRANDRA; STREPTOZOCIN DIABETES;

ALKALOIDS; ANIMALS; BENZYLISOQUINOLINES; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; GLUCOSE; GLYCOGEN; HEPATOCYTES; HYPOGLYCEMIC AGENTS; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; TIME FACTORS;

EID: 2342611153     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357023330     Document Type: Article

References (26)

1. Baron, A. D., Brechtel, G., Wallace, P., Edelman, S. V. (1988) Rates and tissue sites of non-insulin-and insulin-mediated glucose uptake in humans. Am. J. Physiol. 255: E769-E774
2. Berger, J., Biswas, C., Vicario, P. P., Strout, H. V., Saperstein, R., Pilch, P. F. (1989) Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature 340: 70-72
3. Bessesen, D. H. (2001) The role of carbohydrates in insulin resistance. J. Nutr. 131: 2782S-2786S
4. Bollen, M., Keppens, S., Stalmans, W. (1998) Specific features of glycogen metabolism in the liver. Biochem. J. 336: 1-31
5. Cao, Z. F. (1996) Scavenging effect of tetrandrine of active oxygen radicals. Planta Med. 62: 413-414
6. Cerielo, A., Motz, E., Cavarape, A., Lizzio, S., Russo, A., Quatraro, A., Giugliano, D. (1997) Hyperglycemia counterbalances the antihypertensive effect of glutathione in diabetic patients: evidence linking hypertension and glycemia through the oxidative stress in diabetes mellitus. J. Diabetes Complicat. 11: 250-255
7. Cheng, J. T., Liu, I. M., Chi, T. C., Tzeng, T. F., Lu, F. H., Chang, C. J. (2001) Plasma glucose lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 50: 2815-2821
8. Consoli, A., Nurjhan, N., Capani, F., Gerich, J. (1989) Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38: 550-557
9. Felix, J. P., King, V. F., Shevell, J. L., Garcia, M. L., Kaczorowski, G. J., Bick, I. R., Slaughter, R. S. (1992) Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site. Biochemistry 31: 11793-11800
10. Hanson, R. W., Reshef, L. (1997) Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 66: 581-611
11. Hu, G. X., Hu, Y., Fang, D. C., Jiang, M. X. (1987) Hemodynamic effects of tetrandrine in conscious rats. Acta. Pharmacol. Sin. 8: 325-328
12. Huang, Y. T., Hong, C. Y. (1998) Tetrandrine. Cardiovasc. Drug Rev. 16: 1-15
13. James, D. E., Jenkins, A. B., Kraegen, E. W. (1985) Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am. J. Physiol. 248: E567-E574
14. Kim, H. S., Zhang, Y. H., Oh, K. W., Ahn, H. Y. (1997) Vasodilating and hypotensive effects of fangchinoline and tetrandrine on the rat aorta and the stroke-prone spontaneously hypertensive rat. J. Ethnopharmacol. 58: 117-123
15. Kosegawa, I., Chen, S., Awata, T., Negishi, K., Katayama, S. (1999) Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats. Clin. Exp. Hypertens. 21: 199-211
16. Lee, J. H., Kang, G. H., Kim, K. C., Kim, K. M., Park, D. I., Choi, B. T., Kang, H. S., Lee, Y. T., Choi, Y. H. (2002) Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Int. J. Oncol. 21: 1239-1244
17. Lieberman, I., Lentz, D. P., Trucco, G. A., Seow, W. K., Thong, Y. H. (1992) Prevention by tetrandrine of spontaneous development of diabetes mellitus in BB rats. Diabetes 41: 616-619
18. Lopez-Candales, A. (2001) Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. J. Med. 32: 283-300
19. Park, P. H., Nan, J. X., Park, E. J., Kang, H. C., Kim, J. Y., Ko, G., Sohn, D. H. (2000) Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Pharmacol. Toxicol. 87: 261-268
20. Shen, Y. C., Chen, C. F., Wang, S. Y., Sung, Y. J. (1999) Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 up-regulation and adhesion by tetrandrine. Mol. Pharmacol. 55: 186-193
21. Sun, G. R., Zhang, G. F., Wei, Y. J., Yang, D. S., Zhang, J. X., Tian, Z. B. (1994) Protective effect of tetrandrine on pancreatic islet cells damaged by alloxan in rats. Acta. Pharmacol. Sin. 46: 161-167
22. Sutter, M. C., Wang, Y. X. (1993) Recent cardiovascular drugs from Chinese medicinal plants. Cardiovasc. Res. 27: 1891-1901
23. Tainlin, L., Tingyi, H., Changqi, Z., Peipei, Y., Qiong, Z. (1982) Studies of the chronic toxicity of tetrandrine in dogs: an inhibitor of silicosis. Ecotoxicol. Environm. Safety 6: 528-534
24. Teh, B. S., Chen, P., Lavin, M. F., Seow, W. K., Thong, Y. H. (1991) Demonstration of the induction of apoptosis (programmed cell death) by tetrandrine, a novel anti-inflammatory agent. Int. J. Immunopharmacol. 13: 1117-1126
25. Tsutsumi, T., Kobayashi, S., Liu, Y. Y., Kontani, H. (2003) Anti-hyperglycemic effect of fangchinoline isolated from Stephania tetrandra Radix in streptozotocin-diabetic mice. Biol. Pharm. Bull. 26: 313-317
26. Ziel, F. H., Venkatesan, N., Davidson, M. B. (1988) Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 37: 885-890